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Bruno Martella, MD,b Padova, Italy
Purpose: Though the peroneal artery (PA) often remains patent despite disease or occlusion of other infrapopliteal
arteries, there is skepticism about using the terminal PA as the outflow tract in distal revascularizations for limb salvage,
especially when a patent inframalleolar artery is available. We analyzed our experience of using the distal PA and
inframalleolar or pedal branches arteries as outflow tracts in revascularizations for critical limb ischemia.
Methods: Over a decade, among 651 infrapopliteal arterial reconstructions performed in 597 patients, the PA was the
outflow vessel in 214, its distal third being involved in 69 vein revascularizations (study group). During the same period,
187 vein bypass grafts were performed to 179 inframalleolar and 8 pedal branches arteries (control group). Patency, limb
salvage and survival rates were assessed using Kaplan-Meier life-table analysis. Complete follow-up (range, 0.1-10.2
years; mean, 5.8 years) was obtained in 245 (95.7%) patients (66 were in the study group).
Results: The distal PA was chosen as the target vessel: (1) because the proximal, mid-PA was occluded or severely diseased
and no other adequate inframalleolar or pedal branches arteries were identified preoperatively (n  30; 43.5%);
(2) because an alternative inframalleolar target vessel was present but severely diseased (n  9; 13%); (3) because of the
length limitations of the available vein (n  12; 17.4%; or (4) because of the presence of invasive infection or necrosis
overlying the dorsalis pedis or posterior tibial arteries (n  18; 26.1%). The study group was significantly younger than
the control group (68 7 years vs 70 6 years, P .039), and included significantly more patients with diabetes mellitus
(65.2% vs 50.2%, P  .033) and insulin dependence (52.2% vs 37.9%, P  .041), dialysis-dependent chronic kidney
disease (5.8% vs 1.1%, P  .047), and history of smoking (75.3% vs 58.2%, P  .012). None of the patients died in the
perioperative period. Although the overall need for minor amputation was statistically higher in the PA group (78.2% vs
63.1%, P  .022), especially as concerns partial calcanectomy (8.7% vs 2.1%, P  .026), the proportion of wounds
completely healed during the follow-up and the mean time to wound healing were comparable in the two groups.
Kaplan-Meier analysis showed comparable long-term patency, limb salvage, and survival rates in the two groups.
Conclusions: Revascularization to the distal third of the PA can achieve much the same outcome in terms of patency and
limb salvage rates, wound healing rate and timing, as when other inframalleolar or pedal branches are used. The
skepticism surrounding use of the terminal PA as an outflow vessel appears to be unwarranted. ( J Vasc Surg 2008;
47:952-9.)Long-term patency and limb salvage (LS) rates after
infrapopliteal arterial revascularization to the peroneal ar-
tery (PA) for critical limb ischemia (CLI) are comparable
with those achieved using other tibial outflow arteries.1-10
Using the PA in lower extremity arterial reconstruction has
always been a controversial issue, however, especially when
a patent inframalleolar artery is available.11-14 The PA is
relatively spared from the terminal stages of atherosclero-
sis1,15 and is often the last tibial vessel to become occluded
in diabetes or end-stage vascular disease.1,2 The main prej-
udice, on the other hand, against its use in distal revascu-
larizations is that perfusion of the foot is indirect, via
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952collaterals from its anterior and posterior branches, de-
spite an extensive collateral arterial bed, so the target
vessel may be inadequate for treating a septic or gangre-
nous foot.11,13,16,17 Inframalleolar vessels include the pos-
terior tibial (PT) artery, at or below the medial malleolus,
the dorsalis pedis (DP) artery, and the pedal branches (PBs)
arteries, defined as any tarsal, plantar, or anterior lateral
malleolar arteries.18 Though these vessels are commonly
exposed in septic areas, which may increase the incidence of
wound complications, inframalleolar reconstructions re-
store a pulsatile, direct arterial perfusion of the ischemic or
septic foot, in close proximity to the ischemic lesion. Prox-
imal and mid-PAs are used as outflow segments, especially
when any other inframalleolar artery is suitable, but the
terminal PA (within 5 cm of the malleolus) is regarded with
skepticism by many authors, who question the efficacy of
such revascularizations in LS and consider exposing the
artery’s distal third demanding.9,19
The purpose of this study was to analyze our experience
of bypass procedures to the distal third of the PA to see
whether such revascularizations could yield comparable or
even better results, in terms of patency and LS rates, wound
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constructions to inframalleolar or PBs arteries in patients
with CLI.
METHODS
From January 1995 to October 2005, all consecutive
patients requiring an infrapopliteal bypass at our institution
for CLI (rest pain and/or ischemic ulceration, or gangrene
limited to the heel or forefoot) were prospectively entered
in a vascular surgery registry. For this study, the registry was
queried to identify patients who underwent autogenous
vein bypass to a terminal PA (study group) or to inframal-
leolar or PBs arteries (control group) as an outflow vessel
up until October 2005. Patients with ischemic soft tissue
breakdown between the calcaneous and metatarsal heads
(plantar region) and those who had bypasses to target
arteries proximal to the ankle or using synthetic conduits
were ruled out.
Demographic data and preoperative risk factors, in-
cluding diabetes mellitus, smoking, arterial hypertension,
coronary artery (CAD), or chronic kidney diseases (CKD),
were recorded for each patient, along with the inflow site.
All patients underwent preoperative standard biplanar arte-
riography or magnetic resonance angiography, and com-
puted tomography angiography, or a combination of these
methods, to confirm the clinical and vascular laboratory
diagnosis (duplex ultrasonography arterial mapping and
ankle-brachial index [ABI] measurement) of CLI and to
plan surgery. The preoperative angiographic findings of the
runoff vessels were assessed according to the revised ad hoc
scoring system proposed by Rutherford et al.20 Because
bypassing to a single tibial artery or the DP are examples of
a normally single-vessel runoff, runoff was assessed grading
the resistance of the pedal arch. A value of 0 was assigned
for a completely patent arch connecting with retrograde
flow back into the other pedal artery (eg, lateral plantar or
medial tarsal), 1 for patent arch with no retrograde outflow,
2 for a diseased or partially occluded arch, and 3 for little or
no arch visualized.20 Arbitrarily, 1 point was added to this
score in bypass grafts to the PA, in recognition of its lack of
direct connection with the pedal artery circulation.20 The
preferred conduit was the reversed autogenous great saphe-
nous vein (SV), which was harvested whenever possible on
the strength of venous mapping by duplex scan, subject to
direct assessment at surgery. When the ipsi- or contralateral
great SV was unsuitable or not entirely available, spliced
veins (great or small SV and arm vein) were used. Short
bypass revascularizations were used when distal superficial
femoral, popliteal, or tibial arteries seeming adequate for
inflow at preoperative angiographic evaluation were in fact
found appropriate by the operating surgeon. None of the
patients underwent in situ bypass grafting. No intraopera-
tive contrast or duplex scan arteriography was performed.
All foot lesions were treated preoperatively according to a
protocol described elsewhere,21 and local wound care was
continued after surgery as necessary. Additional procedures
involving the forefoot or heel were recorded. Taking the
arterial revascularization time for reference, ulcers, or gan-grene were analyzed in terms of the time it took for the
wound to close completely by secondary intent or to heal
completely after any additional procedure.
Operative technique. All revascularizations were per-
formed by the senior surgeon using regional anesthesia
(epidural or spinal) and administering intravenous heparin
(5000 IU) before clamping: the heparin was not reversed
with protamine. In all but four cases, the distal PA was
exposed using a lateral approach requiring segmental fibu-
lectomy. The incision is based laterally over the fibula and,
after freeing it of all muscle and fibrous tissue over a stretch
of at least 8 cm, the bone is resected (in our experience, the
mean length of the remaining distal fibula was 8-10 cm and
no ankle instability was observed in our patient group),
facilitating access to the PA lying just medial to the resected
bone on the flexor hallucis muscle. The medial exposure of
the distal PA involves the longitudinal division of the deep
fascia and the posterior displacement of the gastrocnemious
and soleus muscles. The dissection plane is established
behind the PT vessels where the distal PA and its terminal
branches are easily identified once the tibial nerve has been
retracted anteriorly and the flexor hallucis longus muscle
posteriorly. After proximal and distal arterial exposure, the
distal anastomosis was performed first. All distal anasto-
motic sites underwent standard vein patch angioplasty no
longer than 3 cm, as described elsewhere.21,22 The vein for
the patch was harvested from any available location, includ-
ing SV remnants, arm veins harvested under local anesthe-
sia, and occasionally also SV collaterals. The vein conduit
was routed through the interosseous membrane when PA
was exposed laterally. Heparin infusion was started 6 to 10
hours postoperatively, administering oral warfarin on the
first postoperative day, and continuing anticoagulation
treatment for the next 6 months; 325 mg aspirin was taken
daily thereafter.
Graft surveillance. Endpoints of the study were pa-
tency and LS rates, and death. Postoperative assessments
included clinical examinations with ABI measurement and
duplex scan imaging in all patients at discharge, and duplex
scan imaging after 30 days and then at 3-month intervals
during the first year, then every 6 months thereafter. Follow-
up always included a color duplex investigation of the
inflow artery, the whole vein conduit, both anastomoses,
and the initial tract of the outflow artery. A duplex ultra-
sound scan was considered abnormal if the focal peak
systolic flow velocity was 200 cm/s, the velocity ratio
2.0, or the global graft flow velocity45 cm/s. No color
flow in the graft was indicative of occlusion. The patency
data for patients who died were considered up until the last
time their graft had been found patent. For each endpoint,
we considered the midpoint in the interval between when
the graft had last been found patent and when it was revised
or clearly shown occluded.
Data and statistical analyses. The data are presented
and analyzed with the standards recommended by the ad
hoc committee on reporting standards.20 Primary patency
(PP) was defined as uninterrupted duration of patency of
the original graft without any intervention; primary
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duration of patency assisted by simple measures (primarily
percutaneous transluminal angioplasty [PTA] or patch an-
gioplasty) while the original graft remaining free of throm-
bosis; and secondary patency (SP) was defined as duration
of patency of the original graft that thrombosed but was
kept patent by thrombectomy, thrombolytic therapy, PTA,
patch graft angioplasty, and any other suitable procedure.
LS was defined as preservation of the affected limb with no
need for amputation above the metatarsal level.
Continuous data were compared with Student t test.
Frequencies and categorical data were compared with a 2
or Fisher exact test, as appropriate. A Cox proportional
hazard analysis was used to identify which factors could
influence bypass graft patency and LS. All tests were two-
tailed and statistical significance was inferred at a P value
05. PP, PAP, SP, and LS rates and survival for both groups
were assessed by Kaplan-Meier analysis and the Mantel-
Cox log-rank test was used to compare survival curves
between the groups: results are presented as odds ratios
(OR) and 95% confidence intervals (95% CI) with corre-
sponding P value.
RESULTS
During the study period, 651 infrapopliteal bypass
procedures were performed in 597 patients for CLI at our
institution. The distal anastomosis was located at PA level
in 214 (32.8%) revascularizations, and the outflow vessel
was the terminal PA in 69 cases (69 patients; study group).
Table I. Demographics, risk factors, and preoperative AB
Study group
Patients 69
Procedures 69
Age (yr), mean  SD 68  7
range 55-78
Men 49 (71)
Risk factors
Diabetes mellitus 45 (65.
diet controlled 3 (4.3
oral agent 6 (8.7
insulin-dependent 36 (52.
Creatinine  2.0 mg/dL 13 (18.
dialysis dependence 4 (5.8
Smokinga 52 (75.
CAD 43 (62.
Prior MI 24 (34.
Prior PTA stenting/CABG 19 (27.
Prior stroke 9 (13.
Hypertensionb 46 (66.
Prior inflow procedures 14 (20.
ABI 0.40  0
ABI excluding values  1.2 (medial sclerosis) 0.32  0
CAD, Coronary artery disease; MI, myocardial infarction; PTA, perc
ABI, ankle-brachial index.
adefined by patient history.
bdefined as blood pressure treated with medication.
cFisher test.
dStudent t test.The distal PA was chosen as the target vessel: (1) becausethe proximal, mid-PA was occluded or severely diseased,
and no other adequate inframalleolar or PB arteries were
identified preoperatively (n  30; 43.5%); (2) because an
alternative inframalleolar target vessel was present but se-
verely diseased (n  9; 13%); (3) because of the length
limitations of the available vein (n  12; 17.4%; or 4)
because of the presence of invasive infection or necrosis
overlying the DP or PT arteries (n  18; 26.1%). During
the same period, 187 autologous vein bypass grafts were
performed to 179 inframalleolar (92 TPAs and 87 DPs)
and 8 PB arteries in 187 patients (control group). No
group of patients managed conservatively or undergoing
primary amputation or primary interventional therapy was
considered for comparison. Bypass procedures to arteries
proximal to the ankle or involving prosthetic conduits were
excluded from the analysis.
Preoperative demographic data, risk factors and ABI
measurements for the two groups are shown in Table I. The
population was predominantly male, with significantly
younger patients in the study group (68  7 years vs 70 
6 years, P  .039). The PA group had a statistically higher
incidence of diabetes mellitus (65.2% vs 50.2%, P  .033)
and insulin dependence (52.2% vs 37.9%, P  .041),
dialysis-dependent CKD (5.8% vs 1.1%, P  .047), and
history of smoking (75.3% vs 58.2%, P  .012) than the
control group. The degree of preoperative foot ischemia as
measured by ABI was comparable between the study and
control groups (0.40  0.22 vs 0.43  0.21; P  .317)
and, although it was worse in the study group after patients
surements
) Control group, n (%) P value Total, n (%)
187 256
187 256
70  6.44 .039
59-85
123 (65.7) .428 172 (67.2)
94 (50.2) .033 139 (54.3)
8 (4.2) 1c 11 (4.3)
15 (8.0) .862 21 (8.2)
71 (37.9) .041 107 (41.8)
45 (24.1) .372 58 (22.6)
2 (1.1) .047c 6 (2.3)
109 (58.2) .012 161 (62.9)
113 (60.5) .783 156 (60.9)
51 (27.3) .241 75 (29.3)
39 (20.1) .257 58 (22.6)
17 (9.1) .353 26 (10.1)
121 (64.7) .134 167 (65.2)
47 (25.1) .420 61 (23.8)
0.43  0.21 .317d
0.36  0.14 .062d
us transluminal angioplasty; CABG, coronary artery bypass grafting;I mea
, n (%
.83
2)
)
)
2)
8)
)
3)
3)
8)
5)
0)
6)
3)
.22
.18
utaneowith artificially elevated ABIs due to the medial sclerosis
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significance (0.32 0.18 vs 0.36 0.14; P .062). There
were no statistically significant differences between the
groups in terms of gender, CAD, arterial hypertension,
history of myocardial infarction or CKD, history of cardiac
operations or cerebrovascular events, and previous inflow
procedures. Indications for surgery, inflow sources, type of
conduit, runoff scores, and preoperative foot care proce-
dures are summarized for both groups in Table II.
Perioperative (30-day) results. None of the patients
died in the perioperative period. There were three early
graft failures (one in the PA group) prompting three above-
knee amputations (Table III). No statistically significant
differences emerged between the two groups as concerns
the improvement of the postoperative ABI measurement,
systemic and local perioperative complications, and periop-
erative additional foot care procedures (Table III).
Long-term results. Complete follow-up (range, 0.1-
10.2 years; mean, 5.8 years) was obtained in 245 (95.7%)
patients (66 were in the study group). The PP rates are
given in Fig 1: at 1, 5, and 10 years, they were 87%, 70.8%,
and 67.4% in the PA group and 88%, 71.9%, and 68.4% in
the control group (P  .886; OR  1.038, 95% CI 
0.608-1.777).
The PAP rates are given in Fig 2: at 1, 5, and 10
years, they were 89.7%, 73%, and 69.6% in the PA group
and 89.1%, 75.5%, and 71.7% in the control group (P 
.870; OR  1.047, 95% CI  0.594-1.847). All the
Table II. Indications for surgery, inflow source, type of co
Study group, n (%)
Indications for surgery
Gangrene/nonhealing ulcers 61 (88.4)
toe 43 (62.3)
fore-foot 7 (10.1)
mid-foot 2 (2.9)
hind-foot 9 (13.1)
Rest pain 8 (11.6)
Infection 23 (33.3)
Inflow artery
CFA 44 (63.8)
DFA 3 (4.3)
Distal SFA/AK Popliteal 13 (18.8)
BK popliteal/ TPT 9 (13.1)
Type of conduit
Homo- or contralateral GSV 62 (89.8)
Spliced vein (GSV, SSV, arm) 7 (10.2)
Runoff score
0 0
1 25 (36.2)
2 31 (45)
3 10 (14.5)
4 3 (4.3)
Preoperative foot care procedure
drainage 18 (26.1)
debridement 13 (18.8)
CFA,Common femoral artery;DFA, deep femoral artery; SFA, superficial fe
GSV, great saphenous vein; SSV, small saphenous vein.
aFisher exact test.lesions involved were detected at duplex scan and wereintrinsic vein graft defects equally distributed along the
length of the graft. Graft revision involved three PTAs
(two in the PA group) and four patch angioplasties in the
control group.
The SP rates are given in Fig 3: at 1, 5, and 10 years,
they were 91%, 75.8%, and 72.2% in the PA group and
90.6%, 76.6%, and 72.8% in the control group (P  .989;
OR  0.995, 95% CI  0.551- 1.798). Overall, SP was
achieved in five grafts: three of them (one in the PA group)
failed within the first 3 months after surgery, while two
(one in the PA group) failed 29 and 18 months, respec-
tively, after surgery due to outflow disease secondary to
myointimal proliferation and hyperplasia.
The LS rates are given in Fig 4: at 1, 5, and 10 years,
they were 95.5%, 91.9%, and 91.9% in the PA group and
96.1%, 93%, and 93% in the control group (P  .659;
OR 1.270, 95%CI 0.416-3.982). LS was facilitated by
additional procedures on the foot. Although the need for
minor amputation was statistically more frequent in the PA
group (78.2% vs 63.1%, P  .022), especially when it
concerns partial calcanectomy (8.7% vs 2.1%, P  .026),
the proportion of wounds completely healed during the
follow-up and the mean time to wound healing were com-
parable in the two groups (Table III). Overall, there were
15 major amputations, 9 below the knee (3 in the PA
group) and 6 above the knee (2 in the PA group); only 4 of
them (1 in the PA group) were needed to treat chronic
neuropathic heel ulcer (n  2) or progressive ascending
it, runoff scores, and preoperative foot care procedures
Control group, n (%) P value Total, n (%)
163 (87.2) .790 224 (87.5)
121 (64.7) .724 164 (64.1)
17 (9.1) .797 24 (9.4)
7 (3.7) .545a 9 (3.5)
18 (9.6) .430 27 (10.5)
24 (12.8) .790 32 (12.5)
67 (35.8) .711 90 (35.1)
98 (52.4) .105 142 (55.4)
10 (5.3) .746a 13 (5.1)
55 (29.4) .089 68 (26.6)
24 (12.8) .965 33 (12.9)
175 (93.6) .313 237 (92.6)
12 (6.4) 19 (7.4)
69 (36.9)
86 (46)
28 (15)
4 (2.1)
0
51 (27.3) .850 69 (26.9)
56 (29.9) .076 69 (26.9)
artery;AK, above the knee; BK, below the knee; TPT, tibio-peroneal trunk;ndu
moralgangrene (n 2) despite a patent bypass graft. Two-thirds
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erative year.
All potentially prognostic patient variables (includ-
ing age, gender, diabetes mellitus, CKD or dependence
on dialysis, smoking, CAD, prior myocardial infarction
or cardiac interventions, arterial hypertension, prior
stroke or inflow procedures and inflow source, and run-
off scores) were submitted to univariate or multivariate
Cox proportional hazards analysis as possible predictors
of bypass failure: none of these variables emerged as a
significant predictor either in the series as a whole or in
either group.
Overall, there were 55 late deaths, 16 of them in the PA
group. The survival rates are given in Fig 5: at 1, 5, and 10
years, they were 100%, 71.4%, and 59.9% in the PA group
and 98.8%, 67.5%, and 58.1% in the control group (P 
.584; OR  0.852, 95% CI  0.480-1.512).
DISCUSSION
Although revascularization to infrapopliteal arteries has
proven to be a safe, effective, and durable procedure for LS
in the critically ischemic foot,1-10 the terminal PA has rarely
been considered as a suitable outflow option23 because the
PA lacks continuity with the pedal arteries, and exposing
the distal third of the vessel can prove troublesome.
After arterial reconstruction using the terminal PA, our
patency and LS rates were comparable with those achieved
during the same period using the other inframalleolar ar-
teries, though they were slightly lower for the PA group in
all analyses at 5 and 10 years. These findings are in contrast
with the higher 4-year LS rate of 160 tibial and pedal bypass
Table III. Perioperative (30-day) results, and rate and tim
Study group, n (%)
Death 0
Major amputation 1 (1.4)
ABI measurements 0.89  0.12
Systemic complications 17 (24.6)
Nonfatal MI 1 (1.4)
Heart failure 3 (4.3)
Pneumonia 4 (5.8)
Arrhythmia 7 (10.1)
Renal failure 2 (2.9)
Minor complications 7 (10.1)
Hematoma 3 (4.3)
Lymphocele 2 (2.9)
Wound dehiscence 2 (2.9)
Additional local procedures 16 (23.2)
Drainage 10 (14.5)
Debridement 6 (8.7)
Minor amputation 54 (78.2)
Toe(s), ray(s) 41 (59.4)
Transmetatarsal 7 (10.1)
Partial calcanectomy 6 (8.7)
Wounds healed 43 (70.4)
Time to wound healing, wk 23  19.9
MI, Myocardial infarction.
aFisher exact test.
bStudent t test.grafts compared with 34 PA bypass procedures (67% vs55%, P  .017) reported by Elliott et al16 who identified a
PA length  10 cm as one of the four anatomical features
associated with failure after PA bypass grafting. In a later
study, the same authors compared the results of PA and
inframalleolar bypasses for ischemic tissue loss (including,
however, only 18 PA bypasses performed for tissue loss)
and concluded that PA revascularization afforded a 3-year
LS rate statistically lower to that of the inframalleolar
bypasses (33% vs 63%; P  .048) when the indication for
surgery was tissue necrosis.17 On the other hand, our
patency and LS rates correlate well with the only previously-
published study dealing with the terminal PA being used in
primary or secondary distal revascularizations for CLI be-
cause a more proximal outflow vessel was unavailable:23 in
a series of 159 revascularizations performed in 143 patients
during a 14-year period, Darling et al23 reported 1- and
5-year SP rates of 86% and 75%, respectively, with a 5-year
LS rate of 87%, demonstrating that these reconstruction
procedures achieved much the same hemodynamic results
as PT or DP, and PB bypass grafts. Revascularizations
to the distal third of the PA were also found as reliable
in effecting LS as the proximal two thirds of the PA or
other perimalleolar arteries in the same investigators’
hands,1,5,8,10 and their results were comparable with those
obtained by many authors advocating the use of PA bypass
procedures for LS, though none of them specifically fo-
cused on the terminal PA.2-4,6,7,9
In our study, the mean time to wound healing and
the proportion of wounds completely healed during the
follow-up were similar after distal PA or inframalleolar and
of wound healing
Control group, n (%) P value Total, n (%)
0 0
2 (1.1) 1 3 (1.2)
0.94  0.21 .063b
31 (16.5) .143 48 (18.7)
1 (0.5) .467a 2 (0.8)
2 (1.1) .123a 5 (1.9)
6 (3.2) .466a 10 (3.9)
20 (10.7) .899 27 (10.5)
2 (1.1) .294a 4 (1.5)
24 (12.8) .558 31 (12.1)
14 (7.5) .572a 17 (6.6)
6 (3.2) .630a 8 (3.1)
4 (2.1) .662a 6 (2.3)
47 (2.1) .748 63 (24.6)
29 (15.5) .841 39 (15.2)
18 (9.6) .821 24 (9.3)
118 (63.1) .022 172 (67.1)
98 (52.4) .318 139 (54.3)
16 (8.5) .693 23 (8.9)
4 (2.1) .026a 10 (3.9)
147 (80.3) .109 190 (74.2)
20  8.9 .107ingPBs bypasses, despite a significantly higher incidence of
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tomy) in the PA group. We, consequently, confute the
assumption that the lack of any direct connection between PA
and the pedal vessels, or the reduced collateral bed when the
terminal PA is involved, reduces the chances of healing
open foot wounds in ischemic, often infected, or contami-
nated fields.1,7,16 In a series of 62 bypasses to the PA,
Shortell et al2 found no correlation between patency and
direct communication with the pedal vessels, and Synn
et al3 and Plecha et al4 were unable to demonstrate any
correlation between patency and preoperative angiographic
scores. Moreover, in a study on the clinical and hemody-
namic results of bypasses to isolated tibial artery segments,
Belkin et al24 found hemodynamic graft failures no more
common with distal PA than with other distal reconstruc-
tions.
Particular features of our study were that: (1) all but
four terminal PAs were exposed through a lateral approach;
(2) the surgical technique involved standard vein patching
Fig 1. Kaplan-Meier life table analysis of primary patency rates in
the study (diamonds) and control (squares) groups. Percentages on
the right represent the primary patency rates at 10 years for the
groups. Standard errors exceed 10% after 7.2 years in both groups.
Raw number of the limbs at risk analyzed for each interval time is
shown for each group.
Fig 2. Kaplan-Meier life table analysis of primary “assisted” pa-
tency rates in the study (diamonds) and control (squares) groups.
Percentages on the right represent the primary “assisted” patency
rates at 10 years for the groups. Standard errors exceed 10% after
7.2 years in both groups. Raw number of the limbs at risk analyzed
for each interval time is shown for each group.and subsequent implantation of the vein graft in the patch;and (3) all patients received adequate anticoagulation
therapy.
Unlike the majority of authors who expose the PA
through a medial route,1,4,5,8,10,23 like Dardik et al25 and
Kahn et al,26 we found that the lateral approach to the PA
provides excellent exposure of the PA distal tract, and, in
our opinion, it is quicker and easier than the medial ap-
proach.
To our knowledge, no other authors (apart from Lin-
ton and Wilde27) have used venous patching at distal
anastomotic level when the conduit was the vein. To over-
come technical difficulties encountered in anastomosing
small-caliber, thin-walled vein conduits to thick-walled dis-
eased arteries, and to contain the compliance mismatch
between the target artery and the vein conduit, since 1986
our technique has involved standard vein patching and then
the implantation of the conduit in the patch in all infrap-
opliteal distal anastomoses.28
Complementary therapy with warfarin is reportedly
Fig 3. Kaplan-Meier life table analysis of secondary patency
rates in the study (diamonds) and control (squares) groups.
Percentages on the right represent the secondary patency rates
at 10 years for the groups. Standard errors exceed 10% after 7.2
years in both groups. Raw number of the limbs at risk analyzed
for each interval time is shown for each group.
Fig 4. Kaplan-Meier life table analysis of limb salvage rates in the
study (diamonds) and control (squares) groups. Percentages on the
right represent the limb salvage rates at 10 years for the groups.
The range of standard errors for the study group is 0% to 3.8%,
whereas the range of standard errors for the control group is 0% to
3.1%. Raw number of the limbs at risk analyzed for each interval
time is shown for each group.important in improving the patency rates of prosthetic graft
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vessels, whereas the benefit of anticoagulation therapy in
patients with venous distal revascularizations appears con-
troversial.29-31 Because we used both vein patch angio-
plasty and anticoagulation therapy in both our groups, we
cannot say how these factors, alone or in combination, may
have influenced our patency rates.
The major shortcomings of this study are its retrospec-
tive nature (despite a prospective data collection) and the
inadequacy of the sample size for the purpose of detecting
differences between groups with adequate statistical power.
A further limitation concerns the exclusion of patients with
ischemic soft tissue breakdown between the calcaneus and
metatarsal heads. In our experience, however, many pa-
tients with extensive soft tissue loss in the plantar region
undergoing a distal revascularization - whatever the out-
flow vessel chosen or the additional techniques used at the
distal anastomotic site (vein patch or cuff, arteriovenous
fistula) - underwent late major amputation (usually despite
a patent graft) due to recurrent deep infections delaying
healing for months, or because minor postoperative ampu-
tations more proximal than at metatarsal level made walk-
ing awkward or difficult. Had we included these patients
too, our results, in terms of LS, would probably have been
negatively affected by clinical events unrelated to the out-
flow site.
In conclusion, this study offers a useful comparison of
patency, LS, and wound healing times and rates after
revascularization to the distal PA and other inframalleolar
or PB arteries, providing evidence that the choice of out-
flow vessel does not influence the outcome of the arterial
reconstruction. The successful wound healing in the PA
group goes to show that revascularization to the terminal
PA affords adequate tissue perfusion and that the lack of
any direct communication between the PA and the major
pedal vessels is no reason to reject the PA as the last-choice
Fig 5. Kaplan-Meier life table analysis of survival rates in the
study (diamonds) and control (squares) groups. Percentages on the
right represent the survival rates at 10 years for the groups. The
range of standard errors for the study group is 0% to 9.5%, whereas
the range of standard errors for the control group is 0% to 6.1%.
Raw number of the patients at risk analyzed for each interval time
is shown for each group.outflow vessel for distal revascularization.AUTHOR CONTRIBUTIONS
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